| Medical and Health Sciences | Lifetime | 679 | DE 25 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 50 | DE 3 | 99.99 |
| Epidemiology | Lifetime | 42 | DE 3 | 99.93 |
| Hepatology | Lifetime | 29 | DE 2 | 99.79 |
| Immunology | Lifetime | 308 | DE 23 | 99.26 |
| Pharmacology | Lifetime | 432 | DE 27 | 95.49 |
| Epidemiology | 2021-2025 | 5 | DE 1 | 99.98 |
| Hepatology | 2021-2025 | 22 | DE 4 | 99.46 |
| Surgery | 2021-2025 | 320 | DE 14 | 97.76 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 128 | DE 8 | 98.07 |
| Immunology | 2021-2025 | 210 | DE 17 | 95.33 |
| Medical Physiology | 2021-2025 | 364 | DE 15 | 95.06 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 894 | DE 45 | 87.86 |
| Oncology | 2021-2025 | 775 | DE 37 | 87.38 |
| Pathology and Forensic Medicine | 2021-2025 | 409 | DE 33 | 83.39 |
| Infectious Diseases | 2021-2025 | 817 | DE 34 | 79.07 |
| Liver Disease Diagnosis and Treatment | Lifetime | 21 | DE 4 | 99.94 |
| Liver physiology and pathology | Lifetime | 4 | DE 2 | 99.90 |
| Immune cells in cancer | Lifetime | 25 | DE 3 | 99.79 |
| Liver Disease and Transplantation | Lifetime | 50 | DE 3 | 99.77 |
| Liver Diseases and Immunity | Lifetime | 30 | DE 3 | 99.56 |
| Diet, Metabolism, and Disease | Lifetime | 65 | DE 4 | 99.49 |
| Hepatitis B Virus Studies | Lifetime | 147 | DE 12 | 99.53 |
| Hepatitis C virus research | Lifetime | 181 | DE 14 | 99.43 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 113 | DE 7 | 98.89 |
| Phagocytosis and Immune Regulation | Lifetime | 60 | DE 5 | 98.59 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 216 | DE 15 | 98.28 |
| Immune Cell Function and Interaction | Lifetime | 920 | DE 60 | 98.86 |
| Chemokine receptors and signaling | Lifetime | 109 | DE 10 | 98.00 |
| Pancreatitis Pathology and Treatment | Lifetime | 339 | DE 34 | 98.35 |
| Macrophage Migration Inhibitory Factor | Lifetime | 45 | DE 6 | 97.60 |
| Immune Response and Inflammation | Lifetime | 851 | DE 87 | 98.05 |
| Lipid metabolism and disorders | Lifetime | 308 | DE 13 | 96.57 |
| Inflammation biomarkers and pathways | Lifetime | 79 | DE 8 | 95.09 |
| Alcohol Consumption and Health Effects | Lifetime | 867 | DE 30 | 94.77 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 985 | DE 61 | 92.19 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 6 | DE 1 | 99.96 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 2 | DE 1 | 99.58 |
| Liver physiology and pathology | 2021-2025 | 1 | DE 1 | 99.93 |
| Diet and metabolism studies | 2021-2025 | 29 | DE 5 | 99.43 |
| Diet, Metabolism, and Disease | 2021-2025 | 10 | DE 1 | 99.78 |
| Liver Disease and Transplantation | 2021-2025 | 58 | DE 3 | 99.34 |
| Liver Diseases and Immunity | 2021-2025 | 17 | DE 3 | 99.29 |
| Hepatitis B Virus Studies | 2021-2025 | 45 | DE 5 | 98.91 |
| Immune cells in cancer | 2021-2025 | 74 | DE 3 | 98.05 |
| Lipid metabolism and disorders | 2021-2025 | 12 | DE 1 | 98.27 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 62 | DE 4 | 98.08 |
| Hepatitis C virus research | 2021-2025 | 93 | DE 6 | 98.07 |
| Immune Cell Function and Interaction | 2021-2025 | 557 | DE 34 | 93.83 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 474 | DE 20 | 95.19 |
| Alcohol Consumption and Health Effects | 2021-2025 | 182 | DE 7 | 92.61 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 576 | DE 24 | 92.40 |
| Fibroblast Growth Factor Research | 2021-2025 | 117 | DE 7 | 86.61 |
| Diabetes and associated disorders | 2021-2025 | 672 | DE 46 | 88.61 |
| Drug-Induced Hepatotoxicity and Protection | 2021-2025 | 371 | DE 9 | 84.02 |
| Phagocytosis and Immune Regulation | 2021-2025 | 399 | DE 12 | 76.72 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 880 | DE 34 | 80.02 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 462 | DE 50 | 76.96 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 933 | DE 61 | 73.42 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 821 | DE 72 | 69.89 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 720 | DE 69 | 58.61 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 523 | DE 47 | 39.04 |